Oramed Pharmaceuticals Inc. (ORMP) — 分析师展望 / 分析师共识目标价为. 基于 8 位分析师评级, 共识为 看涨 — 6 买入, 2 持有.
分析师预估 每股收益(EPS)为 $-0.24 和 营收为 $0.00B (下一财年).
每股收益(EPS)历史表现: 2024: 实际 $-0.47 vs 预期 $-0.24 (不及预期 -95.8%). 2025: 实际 $1.53 vs 预期 $-0.34 (超预期 +550%). 分析师准确度: 14%.
ORMP 分析师评级
Buy
基于过去3个月内 8 位分析师对 Oramed Pharmaceuticals Inc. 的评级
EPS 预测 — ORMP
14%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual –$0.47
vs Est –$0.24
▼ 48.9% off
2025
Actual $1.53
vs Est –$0.34
▲ 122.2% off
Profitability Outlook
Company has mixed profitability — some years profitable, some at a loss. EPS trend is improving.
营收预测 — ORMP
100%
Analyst Accuracy
Accurate
1 year compared
Actual vs Estimate
2025
Actual $0.002B
vs Est $0.002B
▼ 0.0% off
Revenue Trend
Revenue has been relatively flat. Analysts forecast revenue contraction ahead.
